Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2007/04/06 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Prostate Health Plus | 405692 | Medicine | A | 3/3/2023 | |
| Muscle Builder Tablets | 134847 | Enervite (NSW) Pty Ltd | Medicine | A | 2/12/2007 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| ALLERGENIC EXTRACT - POLLENS | 02226928 | Solution - Percutaneous
,
Subcutaneous
,
Intradermal | 40000 UNIT / ML | 12/5/1997 | |
| PACIFIC GRASSES & WEED POLLEN VACCINE | bencard allergy laboratories, an allergy therapeutics (canada) ltd. company | 00061441 | Liquid - Subcutaneous | null NIL / NIL | 12/31/1955 |
| NON STANDARDIZED ALLERGENIC EXTRACTS - POLLENS | greer laboratories inc | 02372444 | Liquid - Intradermal
,
Subcutaneous | 40000 UNIT / ML | 2/10/2012 |
| ALLERGENIC EXTRACTS - POLLENS INJ | hollister-stier, unit pharm, division of miles canada inc. | 00662283 | Powder For Solution - Subcutaneous | null NIL / NIL | 12/31/1990 |
| ALLPYRAL ALLERGEN EXT POLLENS | miles labs ltd. | 00522465 | Liquid - Subcutaneous | null NIL / NIL | 12/31/1982 |
| ALLERGENIC EXTRACT POLLENS | hollister-stier, unit pharm, division of miles canada inc. | 00286281 | Liquid
,
Powder - Inhalation
,
Oral
,
Subcutaneous
,
Intradermal
,
Topical | null NIL / NIL | 12/31/1951 |
| ALLERGENIC EXTRACT POLLENS | alk-abello inc | 00299987 | Liquid - Percutaneous
,
Intradermal
,
Subcutaneous | 100000 UNIT / ML | 12/31/1963 |
| ALLPYRAL - POLLEN - LIQ SC | Bayer Corporation | 02224097 | Liquid - Subcutaneous | null NIL / NIL | 1/30/1997 |
| THC #18 LIQ | total health centre | 01901893 | Liquid - Oral | 30 C / C | 12/31/1994 |
| ALLERGENIC EXTRACTS OF POLLENS | bencard allergy laboratories, an allergy therapeutics (canada) ltd. company | 00061387 | Liquid - Intradermal
,
Subcutaneous | null NIL / NIL | 12/31/1955 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.